Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Xencor Inc
(NQ:
XNCR
)
17.67
+1.00 (+6.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Xencor Inc
< Previous
1
2
3
Next >
Xencor Reports Second Quarter 2024 Financial Results
August 05, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Regains CD20 x CD3 Bispecific T-Cell Engager
June 13, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Reports First Quarter 2024 Financial Results
May 09, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Appoints Bart Cornelissen as Chief Financial Officer
April 09, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at Upcoming Investor Conferences
February 28, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
February 20, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Xencor, Inc.
Via
Business Wire
Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy
January 02, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 Million
November 07, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting
November 03, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023
October 31, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Announces Planned Retirement of Chief Financial Officer John Kuch
October 26, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present Multiple Posters at the SITC Annual Meeting
September 27, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors
September 19, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Second Quarter 2023 Financial Results
August 03, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023
July 27, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 Congress
May 30, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Reports First Quarter 2023 Financial Results
May 08, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023
May 01, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Appoints Nancy Valente, M.D., as Chief Development Officer
April 26, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Highlights CD28 Bispecific Antibody Platform at AACR Annual Meeting 2023
April 17, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present Preclinical Data from Novel XmAb® CD28 Bispecific Antibody Programs at the American Association for Cancer Research Annual Meeting 2023
March 14, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023
February 16, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From
Xencor, Inc.
Via
Business Wire
3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
January 13, 2023
Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways.
Via
MarketBeat
Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates
January 09, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Xencor, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.